The Influenza Vaccines R&D Roadmap, the product of a 2-year collaborative, consensus-building process among a diverse group of global stakeholders, was launched on September 30, 2021.

A press briefing was held on September 30 and included remarks from speakers and a Q&A session with participants.

Speakers included: Dr. Michael Osterholm, Dr. Charlie Weller, Dr. Martin Friede, and Dr. Gagandeep (Cherry) Kang